Form 4: ORTHOPEDIATRICS COO/CFO Reports Routine Stock Transactions

ORTHOPEDIATRICS Corp. COO and CFO Fred Hite reported the acquisition of 77,405 shares and the sale of 12,993 shares to cover tax obligations, as part of a pre-planned transaction.

Summary

• Fred Hite, the Chief Operating Officer and Chief Financial Officer of ORTHOPEDIATRICS CORP, reported changes in his beneficial ownership of common stock.
• On March 15, 2026, Hite acquired 77,405 shares of common stock at a price of $0 per share.
• On March 16, 2026, Hite disposed of 12,993 shares of common stock at a price of $17.25 per share.
• The sale of 12,993 shares was conducted to satisfy tax withholding obligations upon the vesting of restricted shares.
• Following these transactions, Hite beneficially owns 277,477 shares of common stock, which includes 197,765 restricted stock awards.
• The reported transactions were made pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While there is a sale of shares, it is for tax purposes and part of a pre-planned vesting schedule, which is routine. The underlying acquisition of a significant number of shares through a grant is a positive for insider alignment.

Positives

• The acquisition of 77,405 shares of common stock, even if a grant, increases the insider's overall beneficial ownership and aligns management interests with shareholders.
• The continued substantial beneficial ownership of 277,477 shares, including a significant portion of restricted stock, demonstrates ongoing commitment from a key executive.

Negatives

• The disposition of 12,993 shares, while for tax purposes, represents a reduction in direct share ownership by a key executive.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• Shares sold to satisfy tax withholding obligations upon vesting of restricted shares.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to restricted stock vesting and tax withholding, are common occurrences across all industries. These types of transactions are generally considered routine and do not typically reflect a change in management's confidence in the company's prospects, especially when executed under a Rule 10b5-1 plan.

Stakeholder Impact

• Shareholders: The transactions are routine and pre-planned, unlikely to have a significant direct impact on shareholder value. The increase in beneficial ownership through the grant could be seen as a positive for alignment.

Key Dates

Recommendation

A 'hold' recommendation is appropriate as this Form 4 filing details routine insider transactions, specifically the vesting of restricted stock and subsequent sale to cover tax obligations, executed under a Rule 10b5-1 plan. These types of transactions do not typically signal a change in the company's fundamental outlook or management's confidence, and therefore do not warrant a strong buy or sell action based solely on this information. Investors should consider broader company performance and market conditions.

Keywords

ORTHOPEDIATRICS, KIDS, Fred Hite, COO, CFO, Insider Trading, Form 4, Stock Transaction, Restricted Stock, Tax Withholding, Beneficial Ownership, Rule 10b5-1